Novavax
NVAX
#5727
Rank
โ‚ฌ1.16 B
Marketcap
7,04ย โ‚ฌ
Share price
-3.02%
Change (1 day)
28.06%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): -1,30ย โ‚ฌ

According to Novavax's latest financial reports the company's current EPS (TTM) is -1,39ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 2,50ย โ‚ฌ an increase over its 2024 EPS that were of -1,12ย โ‚ฌ.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,30ย โ‚ฌ-152.21%
20252,50ย โ‚ฌ-322.76%
2024-1,12ย โ‚ฌ
2022-7,56ย โ‚ฌ-64.36%
2021-21,22ย โ‚ฌ243%
2020-6,19ย โ‚ฌ19.75%
2019-5,17ย โ‚ฌ-43.86%
2018-9,20ย โ‚ฌ-19.84%
2017-11,48ย โ‚ฌ-38.83%
2016-18,77ย โ‚ฌ74.58%
2015-10,75ย โ‚ฌ63.89%
2014-6,56ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,78ย โ‚ฌ-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,65ย โ‚ฌ-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6,49ย โ‚ฌ-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2,62ย โ‚ฌ-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-2,40ย โ‚ฌ 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,96ย โ‚ฌ 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
1,84ย โ‚ฌ-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-0,40ย โ‚ฌ-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-1,23ย โ‚ฌ-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-4,59ย โ‚ฌ 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA